Samantha Pearce - 02 Aug 2024 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: EVP, Chief Commercial Officer
Signature: By: /s/Adam Guttmann, as attorney in fact For: Samantha J Pearce
Issuer symbol: JAZZ
Transactions as of: 02 Aug 2024
Net transactions value: $0
Form type: 4
Filing time: 06 Aug 2024, 16:53:52 UTC
Previous filing: 07 Mar 2024
Next filing: 22 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Award	$0	+6,996	+41%	$0.000000	24,078	02 Aug 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of August 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
F2	Includes 160 ordinary shares acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan.

Content

These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of August 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Includes 160 ordinary shares acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan.